Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
11/2010
11/18/2010WO2010100133A3 Indole derivatives for treating neurodegenerative diseases
11/18/2010WO2010049952A3 A novel process for the preparation of eletriptan
11/18/2010WO2009156735A3 New therapeutic agents
11/18/2010US20100292500 Npy y5 antagonist
11/18/2010US20100292488 Organic dyes and photoelectric conversion devices
11/18/2010US20100292292 Treatment of Neurodegenerative Diseases Using Indatraline Analogs
11/18/2010US20100292289 Treatment of metabolic syndrome with novel amides
11/18/2010US20100292229 Tryphostin-analogs for the treatment of cell proliferative diseases
11/18/2010US20100292215 11beta-hydroxysteroid dehydrogenase type 1 active compounds
11/18/2010US20100292187 Methods for treating hepatitis c
11/18/2010US20100292157 Combination Treatments for Alzheimer's Disease and Similar Diseases
11/18/2010US20100291706 Dye conjugates and methods of use
11/18/2010CA2762022A1 Redox drug derivatives
11/17/2010EP2251327A2 Heterocyclic inhibitors of MEK and methods of use thereof
11/17/2010EP2251326A1 Heterocyclic compound
11/17/2010EP2251324A1 Heteroaryl-alkylcarbamate compounds and their use as inhibitors of the faah enzyme
11/17/2010EP2250162A2 Amide derivatives as positive allosteric modulators and methods of use thereof
11/17/2010EP2250150A1 Leukotriene b4 inhibitors
11/17/2010EP2249828A1 Preparation of sulfamide derivatives
11/17/2010EP1628956B1 A process for the preparation of compounds having an ace inhibitory action
11/17/2010EP1491206B1 Use of peptide derivatives for inducing cell differentiation
11/17/2010CN101888997A Synthesis of quaternary salt compounds
11/17/2010CN101888841A Thrombopoietin receptor agonist (TpoRA) kills acute human myeloid leukemia cells
11/17/2010CN101885700A Spiroketal-substituted cyclic ketoenols
11/17/2010CN101885699A Method for synthesizing chiral polycyclic compounds having butyrolactam skeletons
11/17/2010CN101223139B 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
11/16/2010US7834193 industrial production of silodosin (for treating dysuria associated with benign prostatic hyperplasia) via mixing 3-{7-cyano-5-[(2R)-2-({2-[2-(2,2,2-trifluoroethoxy)-phenoxy]ethyl}amino]propyl]-2,3-dihydro-1H-indol-1-yl}-propyl benzoate and oxalic acid, nitrilizing, hydrolyzing
11/16/2010US7834070 epoxy resins modified by a mixture of bismaleimides, maleimides and barbituric acids, used for adhesion and insulation of electronics
11/16/2010US7834054 Hydroxamates as therapeutic agents
11/16/2010US7834049 Integrin expression inhibitor
11/16/2010US7834048 7-(sulfonamido-aryl substituted)-3-azabicyclo[3.2.0]heptane compounds; Parkinson's disease, schizophrenia, depression, anxiety, addiction, renal disorders, eating disorders
11/16/2010US7834047 Arylsulfonamides and uses related thereto
11/16/2010US7834037 5-lipoxygenase-activating protein (FLAP) inhibitors
11/16/2010US7834010 gastrointestinal disorders, urinary tract disorders such as hyperactive bladder, and cardiovascular disorders without side effects related to CNS activity; acid moiety makes drug unable to cross the blood-brain barrier; carboxy, phosphonic, sulfonic, or phosphoric acid derivative of piboserod (DDL-6001)
11/16/2010US7834004 N-sulfonyl heterocyclic ring such as piperazine connected via sulfonyl group to another fused heterocyclic ring such as benzothiophene or indoline; peroxisome proliferator-activated receptor (PPAR); obesity, diabetes, hyperinsulinemia, metabolic syndrome X, polycystic ovary syndrome
11/16/2010US7833756 Methods of labelling polynucleotides with dibenzorhodamine dyes
11/16/2010CA2622452C Hemodynamics improving agent
11/16/2010CA2389165C Substituted indoles for modulating nfkb activity
11/11/2010WO2010129636A2 Lenalidomide polymorph
11/11/2010WO2010128120A1 Novel indicator platform
11/11/2010WO2010127786A1 Method for producing oxindoles and ortho-substituted anilines and the use thereof as intermediate products for syntheses
11/11/2010WO2010127452A1 5-oxo-ete receptor antagonist compounds
11/11/2010WO2010054138A3 Modulators of atp-binding cassette transporters
11/11/2010WO2010001179A3 Calcium ion channel modulators & uses thereof
11/11/2010WO2009143178A3 Pde10 inhibitors and related compositions and methods
11/11/2010WO2008120241A3 Novel alcohol solvates of perindopril erbumine
11/11/2010US20100286409 Salts of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide
11/11/2010US20100286404 pharmaceutical intermediates in the synthesis of ace-inhibitors and the use thereof
11/11/2010US20100286225 Diazeniumdiolate compounds, a process for their preparation and pharmaceutical compositions containing them.
11/11/2010US20100286204 Compound capable of inhibiting 17-beta hydroxysteriod dehydrogenase
11/11/2010US20100286189 (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
11/11/2010US20100286144 Heteroaryl derivatives
11/11/2010US20100286073 Compounds and methods for pharmaceutical use
11/11/2010CA2761241A1 Tetracycline compounds
11/10/2010EP2248802A1 Method for producing isoindole and isoindole produced by the method for producing isoindole
11/10/2010EP2248801A1 Inhibitors of cytosolic phospholipase a2
11/10/2010EP2248779A1 Intermediate film for laminated glass and laminated glass
11/10/2010EP2247575A2 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
11/10/2010EP2016053B1 Process for the synthesis of (+) and (-)-1-aryl-3-azabicyclo[3.1.0]hexanes
11/10/2010EP1517886B1 Novel phthalamide derivatives
11/10/2010CN1976900B Methods for producing and purifying 2-hydrocarbyl-3,3-bis(4-hydroxyaryl)phthalimidine monomers and polycarbonates derived therefrom
11/10/2010CN1882333B Indole antiviral compositions
11/10/2010CN101883756A Process for the manufacture of an indolinone derivative
11/10/2010CN101883755A Indolinone derivatives and process for their manufacture
11/10/2010CN101880222A Square acid derivate and preparation method thereof
11/10/2010CN101879160A Application of 3-substituted aryl oxindole in multidrug resistance tumor cells
11/09/2010US7829727 Device containing compound having indolocarbazole moiety and divalent linkage
11/09/2010US7829613 Azinium salts as splayant for layered materials
11/09/2010US7829564 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/09/2010US7829555 noncytotoxic bioreductive drug conjugates, used for targeting a therapeutic agent to a site of hypoxia and/or ischemia within the human or non-human animal body, suitable for the treatment of arthritis, diabetes, atherosclerosis, stroke, sepsis, cancer, Alzheimer's, kidney, digestive or liver disease
11/09/2010US7829257 Alkaline developable photoresists
11/09/2010CA2407659C Growth hormone secretagogues
11/09/2010CA2315953C 3'-epimeric k-252a derivatives
11/04/2010WO2010126881A1 Processes and intermediates
11/04/2010WO2010126811A1 Cxcr3 receptor antagonists
11/04/2010WO2010125923A1 Polymer-supported catalyst and method for producing aromatic hetero compound using the catalyst
11/04/2010WO2010076566A3 Indoles useful in the treatment of inflammation
11/04/2010WO2010074520A3 Novel organic semiconductor compound, method for preparing same, and organic semiconductor composition, and organic semiconductor thin film and element containing same
11/04/2010US20100280259 N-Tert-Butoxycarbonyl-2-Pyrrolidinones and Production Method Thereof
11/04/2010US20100280092 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors
11/04/2010US20100280075 Paclitaxel enhancer compounds
11/04/2010US20100280034 Modulation of pathogenicity
11/04/2010US20100279873 Halogen Alkoxy Spirocyclic Tetramic and Tetronic Acid Derivatives
11/04/2010US20100279340 Imaging agents for protein misfolding
11/04/2010US20100278896 Solid compositions
11/04/2010US20100278811 Vasculostatic agents and methods of use thereof
11/04/2010US20100277063 Fluorene-based derivative and organic electroluminescence device employing the same
11/04/2010US20100277060 Electroluminescent device
11/04/2010CA2760163A1 Processes and intermediates
11/03/2010EP2246347A1 Dicycloazaalkane derivates, preparation processes and medical uses thereof
11/03/2010EP2246328A1 3'-Alkoxy spirocyclic tetronic acid derivatives
11/03/2010EP2246326A1 Method for producing oxindoles and ortho-substituted anilines and their use as intermediate products for syntheses
11/03/2010EP2245010A1 Indoles active on crth2 receptor
11/03/2010EP1805155B1 Thrombopoietin activity modulating compounds and methods
11/03/2010EP1666463B1 Crystal of sulfonamide-containing indole compound and process for producing the same
11/03/2010EP1496838B1 Substituted amides
11/03/2010EP1406615B1 Kinase inhibitors and the use thereof
11/03/2010CN101878552A Organic light-emitting diodes containing carbene transition metal complex emitters and at least one compound selected from disilylcarbazoles, disilyldibenzofurans, disilyldibenzothiophenes, disilyldibenzophospholes, disilyldibenzothiophene s-oxides a
11/03/2010CN101878201A Fused indane compound
11/03/2010CN101878200A Indoline compounds
1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 458